Sepsis study to power new antibiotic discoveries: University of Queensland researchers have led a national study on the four main bacteria that cause sepsis, providing new targets for developing antibiotics. Professor Mark Walker and Professor Mark Schembri from UQ’s Institute for Molecular Bioscience, along with Dr Andre Mu from the University of Melbourne and teams […]
Read More… from Sepsis study to power new antibiotic discoveries
Rapid biomarker diagnostics for Cancers and heart disease: Imperial researchers have built a new easy-to-use test that could diagnose non-infectious diseases like heart attacks and cancers more quickly. The new test works by detecting molecular signals in the body called biomarkers, which are already used in things like COVID-19 testing where the presence of SARS-CoV-2 […]
Read More… from Rapid biomarker diagnostics for Cancers and heart disease
Experts from the University of Nottingham have discovered that reversing the modification of molecular messages at synapses in the human brain, may contribute to reversible mental health conditions such as anxiety, and memory diseases such as dementia. The findings , published in Molecular Psychiatry, are a major step in our understanding how brain cells communicate, […]
SARS-CoV-2 not found in DNA sequencing: University of Queensland researchers are refuting claims that COVID-19 can enter a person’s DNA. The researchers from UQ’s Queensland Brain Institute say the claims have led to “scaremongering” and people should not hesitate to be vaccinated. Professor Geoff Faulkner said his team’s research published in Cell Reports showed there was no evidence of COVID-19 […]
MicroRNAs may contribute to atherogenesis in a cell-type-dependent manner: Researchers at the University of Eastern Finland have uncovered potential mechanisms by which microRNAs (miRNA) drive atherogenesis in a cell-type-specific manner. Published in the Arteriosclerosis, Thrombosis, and Vascular Biology journal, the study provides novel insight into the miRNA profiles of the main cell types involved in atherosclerosis. […]
Scientists at the University of Nottingham have taken a step closer towards developing a treatment for the long-term genetic disorder, myotonic dystrophy. In a paper published today in the journal Science Translational Medicine, scientists from the Schools of Life Sciences and Chemistry at the University, have discovered that by inhibiting a molecule in patients’ cells […]
Read More… from Scientists closer to treatment for myotonic dystrophy
A new treatment delivered as a regular injection could help patients with high cholesterol levels to reduce their risk of cardiovascular disease. Researchers say the drug, which works by silencing genes in the liver and could be delivered by injection at a GP surgery just twice a year, could help those patients with high cholesterol […]